The U.S. formally approved Pfizer’s COVID-19 vaccine in a move that could sway some of the unvaccinated to get a shot.
U.S. stock benchmarks rise solidly Monday morning in what’s expected to be a week dominated by chatter about monetary policy as international centr…
Get news sent directly to your inbox
Get breaking news and incisive analysis sent to your inbox. Choose from a number of free newsletter options at MarketWatch, including Need to Know, which provides a guide to the trading day.